Condition: Retinitis Pigmentosa · Sponsor: jCyte, Inc
This study evaluates the safety of a single injection of jCell (famzeretcel) comprising 6.0 million (6.0M) retinal progenitor cells over a six-month study period in a cohort of adult subjects with RP. Additionally, changes in visual function will be evaluated at six months between the active treatment group (6.0M jCell) compared to sham-treated controls.
This description comes directly from the study's public registry record.
jCyte Sr. Director of Clinical Operations · 949-688-1816 · info@jcyte.com
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants | Phoenix, Arizona, United States | Recruiting |
| California Retina Consultants | Bakersfield, California, United States | Recruiting |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | Recruiting |
| Gavin Herbert Eye Institute, UC Irvine | Irvine, California, United States | Recruiting |
| Retina Consultants Medical Group | Sacramento, California, United States | Recruiting |
| Bay Area Retina Associates | Walnut Creek, California, United States | Recruiting |
| Vitreo Retinal Associates | Gainesville, Florida, United States | Recruiting |
| Georgia Retina | Marietta, Georgia, United States | Recruiting |
| Illinois Retina Associates | Oak Park, Illinois, United States | Recruiting |
| NJRetina | Teaneck, New Jersey, United States | Recruiting |
| Long Island Vitreoretinal Consultants | Westbury, New York, United States | Recruiting |
| Retina Consultants of Texas: Bellaire Retina Center | Bellaire, Texas, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06912633